Smart patch and coach app aim to tame diabetes in pregnancy

NCT ID NCT05662462

Recruiting now Disease control Sponsor: Ohio State University Source: ClinicalTrials.gov ↗

First seen Jun 29, 2026 · Last updated Jun 30, 2026 · Updated 1 time

Summary

This study tests whether a continuous glucose monitor (CGM) paired with a coaching app helps pregnant women with type 2 diabetes achieve better blood sugar control compared to standard care. Participants use a Dexcom G7 CGM sensor and receive guidance through a mobile app and care team. The goal is to see if more women can reach a target A1c below 6.5% in the third trimester, potentially improving outcomes for both mother and baby.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Dexcom G7 Pro Continuous Glucose Monitor and mHealth coaching app
What this could lead to: If successful, this approach could help more pregnant women with type 2 diabetes achieve safe blood sugar levels, reducing risks for both mother and baby.
What could go wrong: This is a relatively small trial (124 participants) and results may not apply to all populations. The intervention adds complexity and may not improve outcomes enough to justify the extra effort.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PRE-GESTATIONAL DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

gestational diabetes Pregnancy in Diabetics type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PRE-GESTATIONAL DIABETES PREGNANCY IN DIABETIC PREGNANCY, HIGH RISK TYPE2DIABETES

Contacts and locations

Locations

The Ohio State University Wexner Medical Center OB/GYN Maternal and Fetal Medicine
RECRUITING

Columbus, Ohio, 43210, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.